Tianjin Mycure Medical Technology Co., Ltd
1 clinical trials · Sponsor
◉ Watch Tianjin Mycure Medical Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL. (NCT03671460) | Tianjin Mycure Medical Technology Co., Ltd | 2018-09-07 |
Track Tianjin Mycure Medical Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.